anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

130,021-130,080 of 319,975

filter-aware
01
Slide 1
The slide uses strong, accusatory language to frame the company as a fraudulent entity, drawing parallels to historical Japanese corporate scandals.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Situation & Context1 hit
02
The slide uses a quote to frame a discussion about the escalation of deception.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Situation & ContextLoop · Aha Moment1 hit
03
Standard investment research disclaimer covering conflicts of interest, lack of investment advice, and limitations of liability.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Situation & ContextLoop · Aha Moment1 hit
04
The slide outlines a forensic accounting argument regarding the manipulation of inventory and balance sheet items to artificially boost profit margins.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Situation & ContextLoop · Aha Moment1 hit
05
The slide details the mechanism of inventory manipulation to inflate profits, comparing the scale of the alleged fraud to historical cases like Olympus and Toshiba.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Loop · Logic Chain1 hit
06
オリンパス事件を前例として引き合いに出し、レーザーテックの棚卸資産比率が業界平均から大きく乖離していることを強調している。Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Loop · Logic Chain1 hit
186
The slide uses a 'villain' framing by characterizing Nevro's technology as 'gimmicky' and 'one-size fits all' while highlighting a competitor's superior clinical outcomes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
187
Uses OpenPayments data to link Nevro's top paid KOLs to the Saluda clinical trial authorship.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
188
The slide uses expert quotes to build a narrative of competitive vulnerability for Nevro.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
189
The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's customer loyalty and future market position.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
190
The slide uses a 'villain critique' style by highlighting the defection of key opinion leaders (KOLs) from the subject company to a competitor.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
191
The slide uses quotes from industry experts to allege unethical behavior and kickbacks in the neuromodulation market.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
192
Includes a direct testimonial quote highlighted in yellow.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
193
Uses quotes from industry participants to validate the thesis of unsustainable pricing pressure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
194
The slide uses expert testimony to contradict potential growth narratives, specifically highlighting a $5,000 price erosion per device.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
195
Uses expert testimony to frame the company's pricing strategy as a terminal failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
196
Uses expert testimony to frame the company's business model as structurally flawed due to customer leverage.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
197
The slide uses highlighted quotes from an ex-executive to frame the company's pricing strategy as a 'stupid move' that destroyed value.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
198
The slide uses a 'villain critique' approach by framing the company's growth story as 'false' and 'misguided' while citing external regulatory bodies to validate the bearish thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
199
The slide uses a series of quotes and summaries from medical and state-level reviews to undermine the company's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
200
Uses highlighted text to emphasize key negative sentiment from KOLs.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
201
Uses direct quotes from 'high volume implanters' to build credibility for the bearish thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
202
Uses direct quotes from high-volume implanters to contradict the market growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
203
The slide uses a series of testimonials to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
204
The slide uses direct quotes from former employees to support the thesis of fraudulent market growth reporting.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
205
The slide uses expert testimony to debunk the company's growth claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
206
Includes a direct testimonial from a high-volume implanter to support the thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
207
The slide uses a direct quote and a news headline to substantiate the claim of unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
208
Includes source links to a German-language publication (SonntagsBlick) and Google Translate versions.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
209
The slide uses external legal commentary to frame the company's business model as a 'textbook case' for potential FCPA violations.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
210
Uses yellow highlighting to emphasize key incriminating phrases in the quotes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
211
The slide uses a combination of a trend line chart, a summary table of payment types, and a detailed table of specific recipient payments to build a case of financial impropriety.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
212
Includes a pull-quote from an ex-Nevro consultant and a snippet from a DOJ press release.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
213
Uses a screenshot of an official government document to frame the company's business model as fraudulent.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
214
Uses yellow highlighting to emphasize key incriminating phrases in quotes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
215
Uses yellow highlighting to emphasize key incriminating phrases in the quotes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
216
The slide uses a series of quotes to build a narrative of corruption and unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
217
The slide uses highlighted text to emphasize key allegations of illegal payments and the prioritization of financial incentives over clinical evidence.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
218
The slide uses inflammatory language ('cesspool', 'exploitation') to frame the company as a villain.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
219
The slide uses the 'ceo-quote-contradiction' framework to frame the CEO's own words as evidence of unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
220
Uses testimonial-style quotes to frame the company as corrupt and exploitative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
221
The slide uses a 'villain critique' approach by framing the company's business model as exploitative and unsustainable.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
222
Uses testimonial evidence to frame the company's sales practices as unethical and exploitative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
223
The slide uses testimonial quotes to frame the company's business model as exploitative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
224
Uses direct quotes from KOLs to substantiate claims of unethical billing and procedure practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
225
The slide uses direct quotes from KOLs to frame the sales representatives as unethical actors.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
226
Uses direct quotes from KOLs (Key Opinion Leaders) to build a case of unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
227
Uses testimonials from former executives and KOLs to support the thesis of financial abuse.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
228
Uses KOL (Key Opinion Leader) quotes to frame the company's business model as exploitative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
229
Uses direct quotes from former employees to build a case of unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
230
Uses testimonial evidence to frame the company's business model as unethical.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
231
The slide uses quotes from KOLs and executives to frame the company's revenue model as exploitative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
232
The slide uses testimonials to frame the company's business model as predatory.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
233
Uses direct quotes from high-volume implanters to substantiate claims of systemic abuse in specific US regions.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
234
The slide uses a 'villain critique' approach by framing the company's core operational model as a criminal liability.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
235
The slide uses direct quotes from KOLs and high-volume implanters to build a case for regulatory/legal risk regarding the unauthorized practice of medicine.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
236
Uses a quote from a former executive to support the claim of unauthorized medical practice.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
237
The slide uses a screenshot of a social media post as primary evidence to support the claim of unauthorized practice of medicine.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
238
Uses direct quotes from former executives to build a case of regulatory and ethical risk.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
239
The slide uses a direct quote from a KOL to support the thesis that Nevro reps are overstepping their professional boundaries.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit